Bacteria resistant to antibiotics: NDM-1 and MRSA


An article in The Lancet Infectious Diseases journal detailed the risk posed by the New Delhi metallo-beta-lactamase-1 enzyme.
The Nursing Times says:

“The enzyme changes the DNA of bacteria to make them immune to carbapenems – medicine’s last line of defence antibiotic.”

The article also details measures which should be taken to prevent the spread of this so-called bug:

“Looking for evidence of travel or treatment in the Indian subcontinent when taking patient histories in general practice, specialist clinics or emergency settings
Advising patients attending travel clinics that if they travel to the Indian subcontinent they need to declare it to healthcare professionals if they are unwell on their return
Ensuring infection control measures are implemented promptly once cases or suspected cases have been identified
Aiming for a zero tolerance approach to healthcare associated infections as there is still scope to drive occurrence rates down further”

Other reports of note include:

The Mayo Clinic has information about the Methicillin-resistant Staphylococcus aureus (MRSA) infection, (caused by a strain of staph bacteria that’s become resistant to the antibiotics commonly used to treat ordinary staph infections.)

Leave a Reply




You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>